Amprenavir/lamivudine/ritonavir/stavudine: Graves' disease (first report with amprenavir) leading to hyperthyroidism: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1109, 2006-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amprenavir/didanosine/stavudine: Acanthosis nigricans in a child (first report with amprenavir): case report

By  

Reactions Weekly, Vol. 1, Iss. 1084, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Antiretrovirals: Polychondritis (first report with lamivudine, abacavir, nevirapine, amprenavir and zidovudine): 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1038, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Ciclosporin interaction: Interaction with concomitant protease inhibitors (first report with amprenavir and fosamprenavir) leading to increased ciclosporin concentrations: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1112, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Fosamprenavir/lamivudine/ritonavir/tenofovir: First report of tenosynovitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Efavirenz/lamivudine/zidovudine: Graves' disease (first report for efavirenz and zidovudine) in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite